ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2 Positive Metastatic Breast Cancer
Interventions: DRUG: ARX788
Sponsor: Ambrx, Inc.